A database on global health research in Africa  by Collins, Francis et al.
Comment
www.thelancet.com/lancetgh   Vol 1   August 2013 e64
A database on global health research in Africa
Over the past decade, global concern about the 
disproportionate burden of disease and mortality 
in low-income countries, especially in sub-Saharan 
Africa, has led to a substantial inﬂ ux of funding for 
research by many donor and research agencies.1 
This investment has energised in-country research; 
advanced the discovery and the use of new treatments 
for HIV/AIDS, tuberculosis, and malaria; and stimulated 
new research strategies for the prevention and control 
of these and other diseases. Questions have been raised 
about whether these international eﬀ orts could be 
better coordinated to increase eﬃ  ciency and improve 
outcomes, while ensuring that research institutions and 
universities are supported with these funds.2 Financial 
support has been uneven; health ministries in some 
sub-Saharan African countries have been overwhelmed 
with many donors seeking to fund research activities, 
whereas neighbouring countries with an equally large 
burden of diseases have a paucity of funding.  
As the heads of nine major research-funding and 
research organisations, we have recognised the need 
to develop a public means to track these international 
research activities and partnered investments, and 
to share our results with the broader research and 
funding community. Such tracking should allow us to 
analyse and understand the landscape of research, to 
identify gaps in funding and areas where there might 
be a duplication of eﬀ ort, and to work more eﬀ ectively 
to synergise our investments. Local investigators could 
also become more aware of programmes supported 
in their institutions to develop local networks and 
collaborations; some African researchers have reported 
ﬁ rst learning about studies done in their own country by 
reading about them in scholarly journals.  The ultimate 
goal of this analysis is to encourage an increase in 
vibrant, productive, competitive, and self-sustaining 
research communities in these settings.  
As a ﬁ rst step, we have provided data for funding from 
our nine organisations’ portfolio of research activities in 
sub-Saharan Africa for 2011–12, so that our institutions’ 
own investments could be mapped and shared with 
others. These data have been organised on a website, 
World RePORT, which was created by the US National 
Institutes of Health and is freely available in a beta-
format. The website is designed to allow communication 
and to improve coordination of biomedical, clinical, and 
health research that was funded by major public and 
private supporters of biomedical research (ﬁ gure). With 
new mapping technologies, each funding organisation’s 
projects are plotted geographically and marked with the 
unique icon of their logo. This research can be searched 
with keywords in project titles and abstracts, and 
ﬁ ltered by country, funding organisation, topic, or any 
combination. Data are summarised by both the funding 
organisation and the institution that does the research. 
Other details given, where available, include project title, 
abstract, principal investigators and their organisation, 
city and country, and hyperlinks that lead to more 
descriptive information. A data-export feature allows 
the user to build individual datasets for further analyses 
and customised reporting. Data are checked for quality 
by the provider and the data entry team, and we plan to 
update this annually.  
The value of the illustrative map and data table 
is immediately evident when seeking locations 
and institutions where research endeavours are 
concentrated and where there are gaps. For example, 
a search with the keyword “malaria” identiﬁ es more 
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Interactive map of research investments made by nine international research funding agencies in sub-Saharan Africa. 
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than 200 separate research eﬀ orts across 17 countries, 
funded by all nine organisations that provided data. By 
contrast, a search with the keyword “diabetes” reveals 
only 16 research activities in seven countries, funded 
by ﬁ ve organisations. Other diseases seem to receive 
little funding, including some that are particularly 
problematic in Africa, such as the neglected tropical 
diseases (eg, Buruli ulcer, yaws, and human African 
trypanosomiasis), the non-communicable diseases 
that are a global priority, and other diseases that 
are especially burdensome in African populations 
(eg, sickle-cell disease). World RePORT gives an overview 
of the clusters of investments in countries. These 
clusters can then be used to identify research institutes 
and universities that are well supported centres of 
excellence, and ﬁ nd gaps where little research is funded 
by our nine organisations. 
We intend for the World RePORT to become a 
powerful programme, available to all, for the simple 
visualisation and consistent monitoring and assessment 
of research funding in low-income and middle-
income regions. We hope the website will identify new 
opportunities for researchers to build more eﬀ ective 
networks, and for governments and donors to consider 
new and more strategic investments. We encourage 
other governments, non-governmental organisations, 
and philanthropic funding agencies to join the eﬀ ort 
to expand World RePORT, ﬁ rst in sub-Saharan Africa, 
and then beyond this region. The availability of a 
comprehensive, timely, and inclusive database could be 
of value to governments, donor agencies, investigators, 
and the broader global health research community, 
particularly for those working in the regions covered by 
the map.
World RePORT is hosted by the US National Institutes 
of Health and managed through a steering committee 
of the agencies providing data. We plan to expand 
the map to parts of Asia and increase the number of 
contributing partners. As a beta-version in testing, 
technical staﬀ  will be improving the programme 
as issues are identiﬁ ed. Both regular updates and 
broad participation by many funders are needed to 
provide a robust and comprehensive view of health-
research eﬀ orts in sub-Saharan Africa, and around 
the world. Our hope is to minimise overlap, maximise 
resources, promote collaboration in our joint aim to 
advance science, and build robust research capacity in 
under-resourced areas, which could lead to improved 
treatment, prevention, and ultimately, better health 
and quality of life.
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Sally Rockey (NIH Deputy Director for Extramural Programs), and staﬀ ed by 
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World RePORT pilot project can be sent to James Onken at 
james.onken@nih.gov. We thank and acknowledge the many contributors of 
the World RePORT steering committee, including: Alana Yuill (Canadian 
Institutes of Health Research), Barbara Kerstiens and Inmaculada Penas Jimenez 
(European Commission), Christiane Walch-Solimena (Max Planck Society), 
Gina Nason (Medical Research Council), Philippe Arhets (INSERM), 
Eliane Coëﬃ  er (Institut Pasteur), Hannah Akuﬀ o (Swedish International 
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